Reagila contains the active substance cariprazine and belongs to a group of medicines called antipsychotics.
It is used to treat adults with schizophrenia.
Schizophrenia is a disease characterised by symptoms such as hearing, seeing or sensing things which are not there (hallucination), suspiciousness, mistaken beliefs, incoherent speech and behaviour and emotional flatness.
People with this condition may also feel depressed, guilty, anxious, tense, or not being able to start or keep up planned activities, unwillingness to speak, lack of emotional response to a situation that would normally stimulate feelings in others.
How to use:
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The recommended starting dose is 1.5 mg once a day by mouth. Thereafter, the dose may be slowly adjusted by your doctor, in steps of 1.5 mg, depending on how the treatment works for you.
The maximum dose should not exceed 6 mg once a day.
Take Reagila at the same time each day with or without food.
If you were taking another medicine to treat schizophrenia before starting Reagila, your doctor will decide whether to stop the other medicine gradually or immediately and how to adjust the dose of Reagila.
Your doctor will also inform you how to act if you switch from Reagila to another medicine.
Caution & Warnings:
Do not take Reagila :
If you are allergic to cariprazine or any of the other ingredients of this medicine
If you are taking medicines used to treat:
- Hepatitis caused by the hepatitis C virus (medicines containing boceprevir and telaprevir)
- Bacterial infections (medicines containing clarithromycin, telithromycin, erythromycin and nafcillin)
- Tuberculosis (medicines containing rifampicin)
- HIV infections (medicines containing cobicistat, indinavir, nelfinavir, ritonavir, saquinavir, efavirenz and etravirine)
- Fungal infections (medicines containing itraconazole, posaconazole, voriconazole and fluconazole)
- Cushing’s syndrome - when the body produces an excess of cortisol (medicines containing ketoconazole)
- Depression (herbal therapy containing St. John's wort (Hypericum perforatum) and medicines containing nefazodone)
- Epilepsy and seizures (medicines containing carbamazepine, phenobarbital and phenytoin)
- Heart disease (medicines containing diltiazem and verapamil)
- Sleepiness (medicines containing modafinil)
- High blood pressure in the lungs (medicines containing bosentan).
Ingredients:
The active substance is cariprazine hydrochloride.
Each hard capsule of Reagila 1.5 mg Hard Capsules contains 1.635 mg cariprazine hydrochloride equivalent to 1.5 mg cariprazine.
Reagila contains the active substance cariprazine and belongs to a group of medicines called antipsychotics.
It is used to treat adults with schizophrenia.
Schizophrenia is a disease characterised by symptoms such as hearing, seeing or sensing things which are not there (hallucination), suspiciousness, mistaken beliefs, incoherent speech and behaviour and emotional flatness.
People with this condition may also feel depressed, guilty, anxious, tense, or not being able to start or keep up planned activities, unwillingness to speak, lack of emotional response to a situation that would normally stimulate feelings in others.
How to use:
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The recommended starting dose is 1.5 mg once a day by mouth. Thereafter, the dose may be slowly adjusted by your doctor, in steps of 1.5 mg, depending on how the treatment works for you.
The maximum dose should not exceed 6 mg once a day.
Take Reagila at the same time each day with or without food.
If you were taking another medicine to treat schizophrenia before starting Reagila, your doctor will decide whether to stop the other medicine gradually or immediately and how to adjust the dose of Reagila.
Your doctor will also inform you how to act if you switch from Reagila to another medicine.
Caution & Warnings:
Do not take Reagila :
If you are allergic to cariprazine or any of the other ingredients of this medicine
If you are taking medicines used to treat:
- Hepatitis caused by the hepatitis C virus (medicines containing boceprevir and telaprevir)
- Bacterial infections (medicines containing clarithromycin, telithromycin, erythromycin and nafcillin)
- Tuberculosis (medicines containing rifampicin)
- HIV infections (medicines containing cobicistat, indinavir, nelfinavir, ritonavir, saquinavir, efavirenz and etravirine)
- Fungal infections (medicines containing itraconazole, posaconazole, voriconazole and fluconazole)
- Cushing’s syndrome - when the body produces an excess of cortisol (medicines containing ketoconazole)
- Depression (herbal therapy containing St. John's wort (Hypericum perforatum) and medicines containing nefazodone)
- Epilepsy and seizures (medicines containing carbamazepine, phenobarbital and phenytoin)
- Heart disease (medicines containing diltiazem and verapamil)
- Sleepiness (medicines containing modafinil)
- High blood pressure in the lungs (medicines containing bosentan).
Ingredients:
The active substance is cariprazine hydrochloride.
Each hard capsule of Reagila 1.5 mg Hard Capsules contains 1.635 mg cariprazine hydrochloride equivalent to 1.5 mg cariprazine.